Skip to main content

Table 2 Treatment outcomes according to RECIST

From: Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients

 

Total number of patients (%)

Clinical response

 CR

8 (28.6%)

 PR

16 (57.1%)

 SD

2 (7.1%)

 PD

2 (7.1%)

Distant recurrence

 Yes

19 (67.9%)

 No

9 (32.1%)

  1. CR complete remission, PR partial remission, SD stable disease, PD progressive disease
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us